Haemodynamic and exocrine effects of caerulein at submaximal and supramaximal levels on the rat pancreas: Role of cholecystokinin receptor subtypes

Pancreatology

Volumn 6, Issue 1-2, 2006, Pages 65-76

  Griesbacher, Thomas ^a   Rainer, Irmgard ^a   Heinemann, Ákos ^a   Groisman, Diana ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Blood flow; Caerulein; Cholecystokinin receptors; Haemodynamics; Vascular conductance

Indexed keywords

1 [2,3 DIHYDRO 2 OXO 1 PIVALOYLMETHYL 5 (2 PYRIDYL) 1H 1,4 BENZODIAZEPIN 3 YL] 3 [3 (METHYLAMINO)PHENYL]UREA; ALPHA METHYL N [(TRICYCLO[3.3.1.1 3,7]DEC 2 YLOXY)CARBONYL]TRYPTOPHYL DEXTRO 3 BENZYL BETA ALANINE; AMYLASE; CERULETIDE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR; GASTRIN 17; HYDROGEN; ICATIBANT; LORGLUMIDE; PD 135158; RECEPTOR SUBTYPE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HEMODYNAMICS; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS FUNCTION; PRIORITY JOURNAL; RAT;

EID: 33646134109     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000090025     Document Type: Article

References (42)

1. Erspamer V, Bertaccini G, De Caro G, Endean R, Impicciatore M: Pharmacological actions of caerulein. Experientia 1967;23:702-703.
2. Erspamer V: Progress report: caerulein. Gut 1970;11:79-87.
3. Lampel M, Kern HF: Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch A Pathol Anat Histol 1977;373:97-117.
4. Watanabe O, Baccino FM, Steer ML, Meldolesi J: Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol 1984;246:G457-G467.
5. Steer ML, Meldolesi J: The cell biology of experimental pancreatitis. N Engl J Med 1987;316:144-150.
6. Willemer S, Bialek R, Adler G: Localization of lysosomal and digestive enzymes in cytoplasmic vacuoles in caerulein-pancreatitis. Histochemistry 1990;94:161-170.
7. Lerch MM, Adler G: Experimental animal models of acute pancreatitis. Int J Pancreatol 1994;15:159-170.
8. Bowen JC, Pawlik W, Fang WF, Jacobson ED: Pharmacologic effects of gastrointestinal hormones on intestinal oxygen consumption and blood flow. Surgery 1975;78:515-519.
9. Fara JW, Madden KS: Effect of secretin and cholecystokinin on small intestinal blood flow distribution. Am J Physiol 1975;258:G552-G556.
10. Demling L, Classen M: The influence of gastrointestinal hormones on local blood flow and H-ion concentration of the human gastric mucosa; in Semb LS, Myren J (eds): The Physiology of Gastric Secretion. Oslo, Universitetsforlaget, pp 18-22.
11. Guth PH, Smith E: The effect of gastrointestinal hormones on the gastric microcirculation. Gastroenterology 1976;71:435-438.
12. Chou CC, Hsieh CP, Dabney JM: Comparison of vascular effects of gastrointestinal hormones on various organs. Am J Physiol 1977;232:H103-H109.
13. Aukland K, Bouwer BF, Berliner RW: Measurement of local blood flow with hydrogen gas. Circ Res 1964;14:164-187.
14. Livingstone EH, Reedy T, Leung FW, Guth PH: Computerized curve fitting in the analysis of hydrogen gas clearance curves. Am J Physiol 1989;257:G668-G675.
15. Bockman DE: Microvasculature of the pancreas. Relation to pancreatitis. Int J Pancreatol 1992;12:11-21.
16. Boden PR, Higginbottom M, Hill DR, Horwell DC, Hughes J, Rees DC, Roberts S, Singh L, Sumanchauhan N, Woodruff GN: Cholecystokinin dipeptoid antagonists: design, synthesis and anxiolytic profile of some novel CCK-A and CCK-B selective and 'mixed' CCK-A/ CCK-B antagonists. J Med Chem 1993;36:552-565.
17. Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN: Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 1990;87:6728-6732.
18. Makovec F, Chistè R, Bani M, Pacini M, Rovati LC, Rovati LA: New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity. Arzneimittelforschung1985;35:1048-1051.
19. Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S, Miyata K: (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4- benzodiazepin-3-yl)-N′-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist. J Med Chem 1997;40:331-341.
20. Lembeck F, Griesbacher T, Eckhardt M, Henke S, Breipohl G, Knolle J: New, long-acting, potent bradykinin antagonists. Br J Pharmacol 1991;102:297-304.
21. Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, König W, Knolle J, Schölkens BA: Hoe 140, a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 1991;102:769-773.
22. Zar JH: Biostatistical Analysis, ed 2. Englewood Cliffs, Prentice-Hall, 1984.
23. Griesbacher T, Tiran B, Lembeck F: Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140. Br J Pharmacol 1993;108:405-411.
24. Griesbacher T, Lembeck F: Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br J Pharmacol 1992;107:356-360.
25. Alexander SPH, Mathie A, Peters JA: 2001 Nomenclature Supplement. Trends Pharmacol Sci 2001;22(suppl):1-145.
26. Fujimoto M, Igano K, Watanabe K, Irie I, Inouye K, Okabayashi T: Effects of caerulein-related peptides on cholecystokinin receptor bindings in brain and pancreas. Biochem Pharmacol 1985;34:1103-1107.
27. Huang SC, Yu DH, Wank SA, Mantey S, Gardner JD, Jensen RT: Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors. Peptides 1989;10:785-789.
28. Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP: International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev 1999;51:745-781.
29. B receptors of the CCK-evoked hyperaemia in rat gastric mucosa. Br J Pharmacol 1995;116:2274-2278.
30. Monstein HJ, Nylander AG, Saleh A, Chen D, Lundquist I, Håkanson R: Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scand J Gastroenterol 1996;31:383-390.
31. Corp ES, McQuade J, Moran TH, Smith GP: Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res 1993;623:161-166.
32. Heinemann Á, Jocič M, Peskar BM, Holzer P: CCK-evoked hyperemia in rat gastric mucosa involves neural mechanisms and nitric oxide. Am J Physiol 1996;270:G253-G258.
33. Mithöfer K, Schmidt J, Gebhard MM, Buhr HJ, Herfarth C, Klar E: Measurement of blood flow in pancreatic exchange capillaries with FITC-labeled erythrocytes. Microvasc Res 1995;49:33-48.
34. Griesbacher T, Rainer I, Tiran B, Fink E, Lembeck F, Peskar BA: Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation. Br J Pharmacol 2003;139:299-308.
35. 2 receptor preserves microcirculation in experimental pancreatitis in rats. Am J Physiol 1998;274:G42-G51.
36. Griesbacher T, Kolbitsch C, Tiran B, Lembeck F: Effects of the bradykinin antagonist, icatibant (Hoe 140), on pancreas and liver functions during and after experimental pancreatitis in rats. Naunyn Schmiedebergs Arch Pharmacol 1995;352:557-564.
37. Dobosz M, Hać S, Mionskowska L, Dobrowolski S, Wajda Z: Microcirculatory disturbances of the pancreas in cerulein-induced acute pancreatitis in rats with reference to L-arginine, heparin, and procaine treatment. Pharmacol Res 1996;36:123-128.
38. 2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide. J Physiol Pharmacol 2001;52:107-126.
39. Machens HG, Senninger N, Runkel N, Frank G, von Kummer R, Herfarth C: Use of the hydrogen clearance technique for measurements of pancreatic blood flow. J Surg Res 1993;55:122-130.
40. Klar E, Schratt W, Foitzik, T, Buhr H, Herfarth C, Messmer K: Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotizing pancreatitis in rabbit pancreas. Dig Dis Sci 1994;39:2639-2644.
41. Schmidt J, Riedel D, Mithöfer K, Ryschich E, Buhr HJ, Herfarth C, Klar E: Quantitative evaluation of pancreatic microcirculation in edematous and necrotizing pancreatitis of the rat. Digestion 1994;55:333-334.
42. Satoh A, Shimosegawa T, Abe T, Kikuchi Y, Abe R, Koizumi M, Toyota T: Role of nitric oxide in the pancreatic blood flow response to caerulein. Pancreas 1994;9:574-579.